These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 28274596)
1. Aberrant expression of deubiquitylating enzyme USP9X predicts poor prognosis in gastric cancer. Fu X; Xie W; Song X; Wu K; Xiao L; Liu Y; Zhang L Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):687-692. PubMed ID: 28274596 [TBL] [Abstract][Full Text] [Related]
2. Decreased expression of BRCA1-associated protein 1 predicts unfavorable survival in gastric adenocarcinoma. Yan S; He F; Luo R; Wu H; Huang M; Huang C; Li Y; Zhou Z Tumour Biol; 2016 May; 37(5):6125-33. PubMed ID: 26611647 [TBL] [Abstract][Full Text] [Related]
3. USP9X expression correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma. Peng J; Hu Q; Liu W; He X; Cui L; Chen X; Yang M; Liu H; Wei W; Liu S; Wang H Diagn Pathol; 2013 Oct; 8():177. PubMed ID: 24152793 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer. Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316 [TBL] [Abstract][Full Text] [Related]
5. UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma. Yang H; Zhang C; Fang S; Ou R; Li W; Xu Y Int J Clin Exp Pathol; 2015; 8(11):13957-67. PubMed ID: 26823707 [TBL] [Abstract][Full Text] [Related]
6. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748 [TBL] [Abstract][Full Text] [Related]
7. Reduced Expression of Deubiquitinase USP33 Is Associated with Tumor Progression and Poor Prognosis of Gastric Adenocarcinoma. Chen Y; Pang X; Ji L; Sun Y; Ji Y Med Sci Monit; 2018 May; 24():3496-3505. PubMed ID: 29802710 [TBL] [Abstract][Full Text] [Related]
8. Clinical and prognosis relevance of COX-2 expression in Tunisian patients with primary gastric adenocarcinoma. Ben Ayed-Guerfali D; Charfi S; Khabir A; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R Cancer Biomark; 2016 Jun; 17(1):67-73. PubMed ID: 27314294 [TBL] [Abstract][Full Text] [Related]
9. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer. Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y Tumour Biol; 2016 Nov; 37(11):15007-15017. PubMed ID: 27655288 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer. Guo J; Zu G; Zhou T; Xing J; Wang Z Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis. Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774 [TBL] [Abstract][Full Text] [Related]
13. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients. Hu X; Huang Z; Liao Z; He C; Fang X Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751 [TBL] [Abstract][Full Text] [Related]
14. [Expression of USP9X in Non-small Cell Lung Cancer and Its Clinical Significance]. Peng J; Hu Q; Liu WP; Liu SL; Wang H Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 May; 46(3):413-6. PubMed ID: 26121864 [TBL] [Abstract][Full Text] [Related]
15. Fibulin-1 functions as a prognostic factor in lung adenocarcinoma. Cui Y; Liu J; Yin HB; Liu YF; Liu JH Jpn J Clin Oncol; 2015 Sep; 45(9):854-9. PubMed ID: 26185140 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of ABI1 expression affects the progression and prognosis of human gastric carcinoma. Cui M; Yu W; Dong J; Chen J; Zhang X; Liu Y Med Oncol; 2010 Sep; 27(3):632-9. PubMed ID: 19554484 [TBL] [Abstract][Full Text] [Related]
17. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Schwickart M; Huang X; Lill JR; Liu J; Ferrando R; French DM; Maecker H; O'Rourke K; Bazan F; Eastham-Anderson J; Yue P; Dornan D; Huang DC; Dixit VM Nature; 2010 Jan; 463(7277):103-7. PubMed ID: 20023629 [TBL] [Abstract][Full Text] [Related]